MDGL

379.1004.45%
CH

Carole Huntsman

Executive VP & Chief Commercial Officer

Ms. Carole Huntsman serves as Chief Commercial Officer and Executive VP of Madrigal Pharmaceuticals, Inc. since November 20, 2023. Ms. Huntsman was Senior Vice President, Head of Specialty Care North America and U. S. Country Lead at Sanofi, where she directed 2,600 team Members across multiple product launches in immunology, neurology, oncology, rare diseases and rare blood disorders. She served as Head of North America, Sanofi Genzyme and US Country Lead at Sanofi-Aventis U. S. LLC since 2020 and had been Head of Multiple Sclerosis, Oncology & Immunology - North America until 2020. She is working for Sanofi Genzyme, the specialty care global business unit of Sanofi. In this role, she is focused on driving the U. S. launches of Dupixent and Kevzara, expanding Sanofi Genzyme’s leadership in Multiple Sclerosis and reestablishing growth in the Oncology business. She joined Sanofi Genzyme in 2012 as Vice President and Multiple Sclerosis Business Unit Head, North America and led the successful launches of both Aubagio and Lemtrada. Most recently, she served as Global Lead, Multiple Sclerosis, with responsibility for the strategic planning and direction for the MS brands in markets globally. Before joining Sanofi Genzyme, she was Senior Vice President, Neurodegenerative Diseases and Rheumatology at EMD Serono. In her pharmaceutical and biotech experience, she has also worked at Pfizer, Inc. and Muro Pharmaceuticals, an ASTA Medica company. Additionally, she was commissioned as an officer in the U. S. Army, spending four years on active duty and more than twelve years in the Army Reserves. She earned her Master’s in Business Administration with a concentration in Marketing and Consulting from Boston College – Wallace E. Carroll Graduate School of Management and her Bachelor of Arts in History from Boston College.

Positions